These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1161 related articles for article (PubMed ID: 3566873)
21. Expression of CD95 antigen and Bcl-2 protein in non-Hodgkin's lymphomas and Hodgkin's disease. Nguyen PL; Harris NL; Ritz J; Robertson MJ Am J Pathol; 1996 Mar; 148(3):847-53. PubMed ID: 8774139 [TBL] [Abstract][Full Text] [Related]
22. [Malignant and benign lymphomas: histologic classification and immunomorphologic studies. Results of 838 cases]. Radaszkiewicz T Wien Klin Wochenschr; 1980 Dec; 92(23):819-33. PubMed ID: 6985528 [TBL] [Abstract][Full Text] [Related]
23. Localization of proliferating cell nuclear antigen (PCNA/Cyclin) in workshop cases of Hodgkin's disease and non-Hodgkin's lymphoma. Kamel OW; Warnke RA; Banks PM Semin Diagn Pathol; 1992 Nov; 9(4):311-4. PubMed ID: 1362284 [TBL] [Abstract][Full Text] [Related]
24. Peripheral T-cell non-Hodgkin's lymphoma following treatment of nodular lymphocyte predominance Hodgkin's disease. Rysenga E; Linden MD; Carey JL; Ross CW; Schnitzer B; Sawdyk M; Maeda K Arch Pathol Lab Med; 1995 Jan; 119(1):88-91. PubMed ID: 7802562 [TBL] [Abstract][Full Text] [Related]
25. The distinction of Hodgkin's disease from T cell lymphoma. Banks PM Semin Diagn Pathol; 1992 Nov; 9(4):279-83. PubMed ID: 1480849 [TBL] [Abstract][Full Text] [Related]
26. Detection of genomic imbalances in microdissected Hodgkin and Reed-Sternberg cells of classical Hodgkin's lymphoma by array-based comparative genomic hybridization. Hartmann S; Martin-Subero JI; Gesk S; Hüsken J; Giefing M; Nagel I; Riemke J; Chott A; Klapper W; Parrens M; Merlio JP; Küppers R; Bräuninger A; Siebert R; Hansmann ML Haematologica; 2008 Sep; 93(9):1318-26. PubMed ID: 18641027 [TBL] [Abstract][Full Text] [Related]
27. An overview of the classification of non-Hodgkin's lymphomas: an integration of morphological and phenotypical concepts. Jaffe ES; Raffeld M; Medeiros LJ; Stetler-Stevenson M Cancer Res; 1992 Oct; 52(19 Suppl):5447s-5452s. PubMed ID: 1394152 [TBL] [Abstract][Full Text] [Related]
28. Fine-needle aspiration cytology of metastatic nasopharyngeal carcinoma in cervical lymph nodes: comparison with metastatic squamous-cell carcinoma, and Hodgkin's and non-Hodgkin's lymphoma. Kollur SM; El Hag IA Diagn Cytopathol; 2003 Jan; 28(1):18-22. PubMed ID: 12508177 [TBL] [Abstract][Full Text] [Related]
30. Leu-M1--a marker for Reed-Sternberg cells in Hodgkin's disease. An immunoperoxidase study of paraffin-embedded tissues. Pinkus GS; Thomas P; Said JW Am J Pathol; 1985 May; 119(2):244-52. PubMed ID: 3887932 [TBL] [Abstract][Full Text] [Related]
31. Nodular lymphocyte predominant Hodgkin's disease and anaplastic large-cell (CD30+) lymphoma: distinct entities or nonspecific patterns? Menestrina F; Chilosi M; Scarpa A Semin Diagn Pathol; 1995 Aug; 12(3):256-69. PubMed ID: 8545592 [TBL] [Abstract][Full Text] [Related]
32. Pathology and "molecular histology' of Hodgkin's disease and the border to non-Hodgkin's lymphomas. Hansmann ML; Küppers R Baillieres Clin Haematol; 1996 Sep; 9(3):459-77. PubMed ID: 8922240 [TBL] [Abstract][Full Text] [Related]
33. Changes in diagnosis of non-Hodgkin's lymphomas over time. Banks PM Cancer Res; 1992 Oct; 52(19 Suppl):5453s-5455s. PubMed ID: 1394153 [TBL] [Abstract][Full Text] [Related]
34. The different expression of key-molecules allows the easy subclassification of Hodgkin's lymphoma cases as well as their distinction from non-Hodgkin's lymphomas. Pileri SA; Marafioti T; Pozzobon M; Sabattini E; Ascani S; Mancini C; Piccioli M; Hansmann ML; Delsol G; Mason DY Pathologica; 2003 Oct; 95(5):227. PubMed ID: 14988978 [No Abstract] [Full Text] [Related]
35. [Pathological classification of malignant lymphoma]. Mukai K Gan No Rinsho; 1988 Apr; 34(5):529-39. PubMed ID: 3260291 [TBL] [Abstract][Full Text] [Related]
36. [Detection of bcl-2/JH gene rearrangements in non-Hodgkin's lymphomas and chronic tonsillitis, but not in Hodgkin's lymphomas. Molecular genetic and immunohistochemical study]. Nolte M; Werner M; Spann W; Schnabel B; von Wasielewski R; Wilkens L; Georgii A Pathologe; 1993 Dec; 14(6):302-6. PubMed ID: 8121883 [No Abstract] [Full Text] [Related]
37. Is fascin really a useful marker in distinguishing between classical Hodgkin's lymphoma and various types of non-Hodgkin's lymphomas in difficult cases? Idrees R; Ahmad Z; Qureshi A; Ahsan A; Pervez S J Clin Pathol; 2010 Jul; 63(7):571-4. PubMed ID: 20591908 [TBL] [Abstract][Full Text] [Related]
38. Mast cell reactivity in lymphoma: a preliminary communication. Sharma VK; Agrawal A; Pratap VK; Nagar AM; Mehrotra ML Indian J Cancer; 1992 Jun; 29(2):61-5. PubMed ID: 1473834 [TBL] [Abstract][Full Text] [Related]
39. Serous effusions in malignant lymphomas: a review. Das DK Diagn Cytopathol; 2006 May; 34(5):335-47. PubMed ID: 16604559 [TBL] [Abstract][Full Text] [Related]